| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0012400 | Intron-Intron | chr6:146258667-146258821 | chr6:145937531-145937685 | 155 nt | 0.3484 |
| hsa_SHPRH_0012500 | Exon-Exon | chr6:146261859-146264934 | chr6:145940723-145943798 | 985 nt | 0.4305 |
| hsa_SHPRH_0012600 | Exon-Exon | chr6:146261859-146264938 | chr6:145940723-145943802 | 79 nt | 0.5063 |
| hsa_SHPRH_0012700 | Exon-Exon | chr6:146261859-146266614 | chr6:145940723-145945478 | 177 nt | 0.4294 |
| hsa_SHPRH_0012800 | Exon-Exon | chr6:146261859-146276490 | chr6:145940723-145955354 | 79 nt | 0.5063 |
| hsa_SHPRH_0012900 | Exon-Exon | chr6:146262759-146275989 | chr6:145941623-145954853 | 2021 nt | 0.4112 |
| hsa_SHPRH_0013000 | Exon-Exon | chr6:146262759-146276490 | chr6:145941623-145955354 | 2522 nt | 0.4076 |
| hsa_SHPRH_0013100 | Exon-Exon | chr6:146264279-146273614 | chr6:145943143-145952478 | 1605 nt | 0.4093 |
| hsa_SHPRH_0013200 | Exon-Exon | chr6:146264279-146276490 | chr6:145943143-145955354 | 1937 nt | 0.4125 |
| hsa_chr6_0217900 | Intergenic-Intergenic | chr6:146264556-146276312 | chr6:145943420-145955176 | 1815 nt | 0.3879 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].